Remote Assessment of Lung Disease and Impact on Physical and Mental Health

Remote Assessment of Lung Disease and Impact on Physical and Mental Health

This cohort study aims to use the open-source RADAR-base mHealth platform to collect and analyze datasets associated with lung disease. This will include continuous data collected from wearable devices (e.g. heart rate, oxygen saturation, respiratory rate), including pulse oximeters, spirometer, mobile phones, digital tests, and smart phone symptom questionnaires.

Inclusion Criteria:

• 20 patients with a diagnosis of COPD
• 20 patients with a diagnosis of interstitial lung disease
• 20 a clinical diagnosis of COVID-19 (within 4-13 weeks of enrolment) who either and report symptoms interfering with day to day activity present for more than 28 days following the onset of COVID-19
• Prior mobile phone use
• Willingness to use monitoring devices and complete study questionnaires.
• History of exacerbation (COPD: 2 or more exacerbations in last 1 yr)

Exclusion Criteria:

• Non English language Speaker
• Lack of physical capability to take part e.g. Heart Failure
• Pregnancy
• Lack of capability to consent